Allopurinol Linked to Reduced Risk for CKD Stage & #8805;3 in Gout

THURSDAY, Oct. 25, 2018 -- For patients with gout, allopurinol is associated with a reduced risk for developing chronic kidney disease stage ≥3, according to a study published online Oct. 8 in JAMA Internal Medicine. Ana Beatriz Vargas-Santos,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news